Close Menu

NEW YORK (360Dx) — French diagnostics firm Novacyt said today that it has entered a convertible bond facility for up to €5.0 million ($5.6 million) with Park Partners and Negma Group.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.